Gapping up
In reaction to strong earnings/guidance:
- VICR +19.7%, CREE +9.7%, STNG +9.7%, JMU +7.9%, SIX +5.6%, (also announces three more Six Flags Parks coming to China), SOHU +5.4%, CS +5%, STM +5%, MANH +4.9%, RHI +4.4%, TXN +4.2%, TWTR +3.5%, VIAB +3.5%, SVU +3.4%, (to sell eight of its owned distribution centers, representing approximately 5.8 million square feet, to a single buyer for an aggregate purchase price, excluding closing costs and taxes, of approximately $483 million; reports earnings), HA +2.9%, TSS +2.8%, SOGO +2.6%, BA +2.4%, IRBT +1.8%, IPHI +1.7%, SLAB +1.7%, JOE +1.4%, YNDX +1.3%, RES +1.3%, SIRI +1.1%, DDR +0.9%, USNA +0.9%, ANTM +0.9%, PAG +0.8%
M&A news:
- SHPG +1.1% (confirmed revised proposal by Takeda Pharma (TKPYY) which implies an equivalent value of approximately GBP 49/share)
Other news:
- MNKD +9.8% (Mannkind moving higher in extended trading as traders circulate FDA document showing that the agency determined that a REMS is no longer required for Afrezza (insulin human) inhalation powder )
- PSTI +6.7% (FDA has cleared its IND for a Phase III study of its PLX-PAD cell therapy in the treatment of muscle injury following surgical repair (arthroplasty) of the hip joint due to fracture)
Analyst comments:
- VZ +0.7% (upgraded to Buy from Neutral at UBS)